North Star Asset Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

North Star Asset Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,100	Closed	-$267K	–	316
2024 Q1	$267K	Hold	11,100	–	–	0.01%	270
2023 Q4	$255K	Hold	11,100	–	–	0.01%	266
2023 Q3	$226K	Hold	11,100	–	–	0.01%	272
2023 Q2	$259K	Hold	11,100	–	–	0.01%	259
2023 Q1	$258K	Hold	11,100	–	–	0.02%	263
2022 Q4	$279K	Hold	11,100	–	–	0.02%	256
2022 Q3	$293K	Buy	+11,100	New	+$343K	0.02%	240

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

North Star Asset Management's IDNA Position: Q2 2024 in Review

North Star Asset Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2024, closing a stake of 11,100 shares — an estimated $267K sold.

North Star Asset Management first reported a position in IDNA in Q3 2022 and held it in 7 quarters. The position peaked at $293K in Q3 2022. 62 funds tracked by Wall St. Rank hold IDNA as of Q2 2024.

North Star Asset Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2024 after selling out during the quarter.
North Star Asset Management sold 11,100 iShares Genomics Immunology and Healthcare ETF shares in Q2 2024, an estimated $267K.
North Star Asset Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2022 and held it in 7 quarters.
North Star Asset Management's iShares Genomics Immunology and Healthcare ETF position peaked at $293K in Q3 2022.
62 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2024.

Based on North Star Asset Management's 13F filing for Q2 2024, filed 5 Aug 2024.